Wall Street JournalEN
F
FRX
Fennec Pharms
8.65
0.15+1.76%Closed09:30 12/11 EST
OPEN/PREV CLOSE8.65/8.50
TODAY RANGE8.65-8.65
VOL130
MARKET CAP237.29M
52 WEEK RANGE5.65-15.43
AVG VOL (3M)2.89K
% TURNOVER0.00%
TURNOVER1.12K
P/E (TTM)-63.7436
% RANGE0.00%
EPS(TTM)-0.1357
P/E(FORWARD)--
P/B-33.8950
BVPS-0.2552
DIVIDEND--
P/S8.30
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP198.74M
SHARES OUTSTANDING27.43M
NEXT EARNINGS03/17-03/24
FREE FLOAT22.98M
LOT SIZE100
EX-DIV DATE09/05/2014
News
Press Releases
Financial Reports
Profile
Dow Jones·11/07 11:13
*Fennec Pharmaceuticals 3Q Loss $5.74M >FRX.T
Dow Jones·11/07 11:13
*Fennec Pharmaceuticals 3Q Loss/Shr 21c >FRX.T
Dow Jones·08/22 13:17
Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·08/14 12:56
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Dow Jones·08/14 12:56
Fennec Pharmaceuticals Price Target Cut to $15.00/Share From $17.00 by Craig-Hallum
Dow Jones·08/13 10:06
*Fennec Pharmaceuticals 2Q Loss/Shr 20c >FRX.T
Dow Jones·08/13 10:05
*Fennec Pharmaceuticals 2Q Rev $7.26M >FRX.T
Dow Jones·08/05 10:26
*Fennec Pharmaceuticals Appoints Jeffrey Hackman as CEO and Director >FENC
Dow Jones·05/15 18:03
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Dow Jones·05/15 18:03
Fennec Pharmaceuticals Price Target Cut to $17.00/Share From $20.00 by Craig-Hallum
Dow Jones·05/15 11:20
Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·05/14 10:07
*Fennec Pharmaceuticals 1Q EPS 41c >FRX.T
Dow Jones·05/14 10:07
*Fennec Pharmaceuticals 1Q Rev $25.4M >FRX.T
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others